FindTrial
Sign In

Toxicity and Cosmesis outcome in hypofractionated radiation therapy for ductal carcinoma in situ of the breast after breast conserving surgery.

Toxicity and Cosmesis outcome in hypofractionated radiation therapy for ductal carcinoma in situ of the breast after breast conserving surgery

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20191223001
Enrollment
Unknown
Registered
2019-12-23
Start date
2018-07-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ductal carcinoma of the breast Ductal carcinoma of the breast Hypofractionation radiation Cosmesis outcome

Interventions

The patients were treated with 42.5Gy/16 fractions to the whole breast with tumor bed boost 16Gy/4 fractions (standard treatment). We would collected photo on the first and the last day of radiation.
followed up toxicities at 1 and 6 months.
No Intervention Other
Taking picture

Sponsors

Chulalongkorn hospital
Lead Sponsor
Chulalongkorn hospital
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age over 18 Pathologically confirm DCIS

Exclusion criteria

Exclusion criteria: Any prior diagnosis of invasive or ductal carcinoma in situ breast cancer in ipsilateral breast Pregnancy Active soft tissue disease; active systemic lupus, erythematosus, or any history of scleroderma, dermatomyositis with active rash Medical, psychiatric or other condition that would prevent the patient from receiving protocol therapy or providing informed consent

Design outcomes

Primary

MeasureTime frame
Breast cosmesis at 6 months 6 months EORTC scale—

Secondary

MeasureTime frame
Toxicities 1 and 6 months CTCAE—

Countries

Thailand

Contacts

Public ContactJirarat Soonthornrak

Radiation Oncology department, Faculty of Medicine, Chulalongkorn University

jirarat.soon@gmail.com0816789800

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026